Intelligence · Clinical Development
Pipeline search results
Programs matching “Astra” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 467 pipeline programs matching "Astra" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Tesaglitazar 0.5 or 1 mg
AstraZeneca
Type 2 Diabetes
1 trial -
Tezepelumab
AstraZeneca
Asthma
2 trials -
Tezepelumab
AstraZeneca
Chronic Obstructive Pulmonary Disease (COPD)
2 trials -
Tezspire 210 mg solution for injection in pre-filled syringe
AstraZeneca AB
Severe Asthma
1 trial -
Tezspire 210 mg solution for injection in pre-filled syringe
AstraZeneca AB
Chronic Rhinosinusitis with Nasal Polyposis
1 trial -
Ticagrelor
AstraZeneca
Acute Coronary Syndrome
1 trial -
Ticagrelor 90 mg
AstraZeneca
Myocardial Infarction
1 trial -
Tozorakimab
AstraZeneca
Viral Lung Infection and Acute Respiratory Failure
1 trial -
Tozorakimab 1
AstraZeneca
Chronic Obstructive Pulmonary Disease (COPD)
1 trial -
Tozorakimab, Tozorakimab-placebo
AstraZeneca AB
Severe viral lung infections
1 trial -
Trastuzumab Deruxtecan
AstraZeneca
Breast Neoplasms
1 trial -
Trastuzumab Deruxtecan
AstraZeneca
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
1 trial -
Trastuzumab deruxtecan
AstraZeneca
Advanced or Metastatic Breast Cancer
1 trial -
Trastuzumab deruxtecan
AstraZeneca
Breast Cancer; HER2-positive; Metastatic
1 trial -
Tremelimumab
AstraZeneca
Hepatocellular Carcinoma
1 trial -
Tropion-Breast05
AstraZeneca AB
Triple-negative Breast Cancer
1 trial -
UC-GTG-2306
Ningbo Cancer Hospital
Castrate-resistant prostate cancer with oligometastases on functional imaging (PSMA or choline/fluciclovine-positron-emission tomography).
1 trial -
Xofigo 1100 kBq/mL solution for injection
Ningbo Cancer Hospital
metastatic Castration-Resistant Prostate Cancer (mCRPC)
1 trial -
Xtandi - soft capsules for Castration resistant prostate c…
Ningbo Cancer Hospital
Castration resistant prostate cancer patients metastatic to bone.
1 trial -
budesonide/formoterol 'as needed' + budesonide placebo bid
AstraZeneca
Asthma
1 trial -
custirsen sodium
Teva Pharma GmbH
Castrate-Resistant Prostate Cancer
1 trial -
exenatide once weekly
AstraZeneca
Type 2 Diabetes Mellitus
2 trials -
volrustomig
AstraZeneca
Locally Advanced Head and Neck Squamous Cell Carcinoma
1 trial -
3124001
Orion Laboratories Pty.
Metastatic castration-resistant prostate cancer.
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.